(Fixes spelling of Soberana, paragraph 2)
HAVANA, June 21 (Reuters) - Cuba said on Monday its three-shot Abdala vaccine against the coronavirus had proved 92.28% effective in last-stage clinical trials.
The announcement came just days after the government said another homegrown vaccine, Soberana II, had proved 62% effective.
(Reporting by Marc Frank; Editing by Peter Cooney)
Our Standards: The Thomson Reuters Trust Principles.